OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth()()

Treatment of glioblastoma (GBM) remains a challenge using conventional chemotherapy, such as temozolomide (TMZ), and is often ineffective as a result of drug resistance. We have assessed a novel nitrone-based agent, OKN-007, and found it to be effective in decreasing tumor volumes and increasing sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Towner, Rheal A., Smith, Nataliya, Saunders, Debra, Brown, Chase A., Cai, Xue, Ziegler, Jadith, Mallory, Samantha, Dozmorov, Mikhail G., Coutinho De Souza, Patricia, Wiley, Graham, Kim, Kyeongsoon, Kang, Shinwook, Kong, Doo-Sik, Kim, Young-Tae, Fung, Kar-Ming, Wren, Jonathan D., Battiste, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251232/
https://www.ncbi.nlm.nih.gov/pubmed/30468988
http://dx.doi.org/10.1016/j.tranon.2018.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251232/
https://www.ncbi.nlm.nih.gov/pubmed/30468988
http://dx.doi.org/10.1016/j.tranon.2018.10.002

Ejemplares similares